Adaptimmune Therapeutics PLC financial data

Symbol
ADAP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Adaptimmune Ltd (to 3/17/2015)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 301 % -23.4%
Debt-to-equity 324 % +48.6%
Return On Assets -55.4 % -62.2%
Operating Margin -1.04K % -558%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.48B shares +49.3%
Common Stock, Shares, Outstanding 1.53B shares +54.3%
Entity Public Float 191M USD -21.7%
Common Stock, Value, Issued 2.08M USD +47.9%
Weighted Average Number of Shares Outstanding, Basic 1.45B shares +46.4%
Weighted Average Number of Shares Outstanding, Diluted 1.45B shares +45.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.68M USD -88.1%
Revenue from Contract with Customer, Excluding Assessed Tax 18.4M USD -74.2%
Research and Development Expense 136M USD +16.9%
General and Administrative Expense 72.8M USD +8.76%
Costs and Expenses 209M USD +13.9%
Operating Income (Loss) -191M USD -69.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -162M USD -45.2%
Income Tax Expense (Benefit) 1.24M USD -50.3%
Net Income (Loss) Attributable to Parent -163M USD -43.1%
Earnings Per Share, Basic -0.12 USD/shares 0%
Earnings Per Share, Diluted -0.12 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 141M USD +17.4%
Accounts Receivable, after Allowance for Credit Loss, Current 8.4M USD +390%
Other Assets, Current 2.84M USD +70.5%
Assets, Current 187M USD -12.6%
Property, Plant and Equipment, Net 48.3M USD -11.2%
Operating Lease, Right-of-Use Asset 19.4M USD +8.29%
Intangible Assets, Net (Excluding Goodwill) 524K USD +18.3%
Assets 258M USD -10.4%
Accounts Payable, Current 6.59M USD +27%
Employee-related Liabilities, Current 6.25M USD +30.7%
Accrued Liabilities, Current 23.1M USD -30.6%
Contract with Customer, Liability, Current 31.5M USD +41.3%
Liabilities, Current 66.4M USD +4.37%
Contract with Customer, Liability, Noncurrent 147M USD +23.6%
Operating Lease, Liability, Noncurrent 18.4M USD -7.75%
Other Liabilities, Noncurrent 1.42M USD +6.38%
Liabilities 234M USD +14.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.72M USD -52.4%
Retained Earnings (Accumulated Deficit) -1.07B USD -18%
Stockholders' Equity Attributable to Parent 24.4M USD -70.9%
Liabilities and Equity 258M USD -10.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32M USD +14.3%
Net Cash Provided by (Used in) Financing Activities 29.2M USD +14816%
Net Cash Provided by (Used in) Investing Activities -358K USD -101%
Common Stock, Shares Authorized 1.7B shares +32.7%
Common Stock, Shares, Issued 1.53B shares +54.3%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.49M USD -129%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 144M USD +18.2%
Deferred Tax Assets, Valuation Allowance 295M USD +83.7%
Deferred Tax Assets, Gross 302M USD +82.2%
Operating Lease, Liability 23.7M USD +3.76%
Depreciation 2.77M USD +67%
Payments to Acquire Property, Plant, and Equipment 102K USD -95.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -164M USD -54.1%
Lessee, Operating Lease, Liability, to be Paid 28.3M USD -0.49%
Property, Plant and Equipment, Gross 97M USD +5.28%
Operating Lease, Liability, Current 5.25M USD +84.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.56M USD +38.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.19M USD +58.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +14.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.62M USD -17.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.36M USD +7.68%
Current Income Tax Expense (Benefit) 1.34M USD -46.5%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.56M USD +35.5%
Operating Lease, Payments 5.86M USD +56.5%
Additional Paid in Capital 1.1B USD +10.5%
Current State and Local Tax Expense (Benefit) 9K USD +80%
Current Federal Tax Expense (Benefit) 1.3M USD -47.8%
Amortization of Intangible Assets 366K USD -54.8%
Deferred Tax Assets, Net of Valuation Allowance 7.1M USD +34.8%
Share-based Payment Arrangement, Expense 13.2M USD -7.89%